Health and Life Sciences news
Ultrapotent compound may help treat C. diff, reduce recurrence
Clostridioides difficile, or C. diff, is the leading cause of health care-associated infection in the U.S.
Novosteo sees growth as it develops injectable drug to heal broken bones
A Purdue University-affiliated startup known for its novel injectable drug to heal broken bones is growing and adding additional scientists to its team. One of those scientists is using his recovery experience from being hit by a moving truck to help other patients.
Pandemic forcing people to find new ways of expressing grief
The initial spread of COVID-19 halted traditional funerals and eliminated, in many cases, the ability to see dying loved ones face-to-face in hospitals.
You can’t get the flu from a flu shot
As the nation prepares for a flu season amid the global COVID-19 pandemic, several myths and misconceptions about the flu vaccine will reappear.
Shaken and stirred: The relation between stress and alcohol
There are many unknowns with the COVID-19 pandemic, but people’s relationship with alcohol and rationale for drinking seem to be consistent.
Is your pet's food making you sick? Study finds many don't know the risk.
Each year, more than 50 million Americans develop gastrointestinal issues that lead them to question the safety of their most recent meals. It’s entirely possible that their distress could be caused not by the food they have eaten, but the meals served to their furry friends.
NIH grant to help fast-track Neurodon’s Alzheimer’s drug development research
A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer’s disease neurodegeneration.
